Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs

Allergy. 2021 May;76(5):1569-1571. doi: 10.1111/all.14643. Epub 2020 Nov 6.

Cristiano Caruso¹, Stefania Colantuono^{1

2}, Barbara Tolusso³, Clara Di Mario⁴, Antonella Pentassuglia⁵, Gabriele Rumi¹, Elisa Gremese^{3

4}, Antonino Romano^{6

7}, Antonio Gasbarrini⁸

¹ Allergy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
² Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
³ Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
⁴ Division of Rheumatology, Università Cattolica del Sacro Cuore, Rome, Italy.
⁵ San Giovanni Battista Hospital, Rome, Italy.
⁶ IRCCS Oasi Maria S.S., Troina, Italy.
⁷ Fondazione Mediterranea G.B. Morgagni, Catania, Italy.
⁸ UOC Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

No abstract available

Keywords: asthma; basophil; eosinophils; interleukins.

Publication types